Saad Z. Usmani, MD, FACP, discusses a new treatment option for newly diagnosed, transplant-ineligible patients with multiple myeloma.
Article includes:
- An important option for patients with multiple myeloma
- Details on the phase 3 trial
- Efficacy and safety profile
